Capital International Investors Astrazeneca PLC Transaction History
Capital International Investors
- $557 Billion
- Q2 2025
A detailed history of Capital International Investors transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital International Investors holds 31,404,983 shares of AZN stock, worth $2.37 Billion. This represents 0.39% of its overall portfolio holdings.
Number of Shares
31,404,983
Previous 31,285,560
0.38%
Holding current value
$2.37 Billion
Previous $2.3 Billion
4.56%
% of portfolio
0.39%
Previous 0.47%
Shares
32 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
499MCall Options Held
7.24MPut Options Held
2.65M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$3.91 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.59 Billion0.45% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.35 Billion0.16% of portfolio
-
Franklin Resources Inc San Mateo, CA21.3MShares$1.6 Billion0.42% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...